
POV: Pharmacist
“Nulla feugiat ipsum arcu mi penatibus fringilla cursus ut mi. At eget condimentum pellentesque in amet.”
The Pharmacist's View >
Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.Intro text here.
The Pharmacist's View >
The Nurse's View >
March 21, 2025
Management of Acute Thromboembolism - Including Arterial Thrombosis, Venous Thrombosis, Pulmonary Embolism, and Cerebral Venous Thrombosis with...
March 17, 2025
Retrospective review investigating the role and outcome of direct oral anticoagulants (DOACs) for the management of HIT.
March 17, 2025
Review of alternative management strategies in patients with HIT undergoing cardiac surgeries, refractory HIT, and HIT and active bleeding.
March 17, 2025
Social Determinants of Health are conditions in the environments where people are born, live, learn, work, play, worship, and age that affect health...
March 17, 2025
The American Society of Hematology (ASH) education program with guidance on the diagnosis and treatment of HIT.
March 17, 2025
Systemic literature review investigating the safety and efficacy of direct oral anticoagulants (DOACs) in the treatment of acute phase of...
March 14, 2025
UNM integrated warfarin dosing guideline for inpatient antithrombosis service and outpatient clinic. Includes warfarin initiating and dosing...
March 14, 2025
A critical review of VKAs and DOACs with focus on their potential for interactions with drugs, foods, herbs and over-the-counter medications
March 14, 2025
Direct Oral Anticoagulants Versus Warfarin in Patients With Isolated Heparin-Induced Thrombocytopenia or Heparin-Induced Thrombocytopenia With...
Clinical FAQs provide practical guidance for healthcare professionals through offering evidence-based answers to common questions. These FAQs cover a wide range of topics to help healthcare professionals deliver high-quality patient care.
What is the clinical relevance of a potential interaction between dexamethasone and DOACs (specifically rivaroxaban and apixaban) in general and in...
Read MoreHow much food needs to be eaten with a rivaroxaban dose and does meal timing (with breakfast, lunch, or dinner) matter?
Read MoreAre DOACs a safe and effective alternative to warfarin in obese patients?
Read MoreJoining the AC Forum is quick, easy, and free—simply complete our online registration form, and you'll instantly access all membership benefits, including newsletters and webinar invitations. By becoming a member, you join a community of excellence dedicated to improving patient care and advancing the management of thromboembolic diseases. Take the next step in your professional journey and register now to start enjoying the benefits of membership today.
"The knowledge I gained from AC Forum has been invaluable in tackling complex patient cases. While I had a solid foundation, the resources and insights provided by AC Forum helped me expand my expertise significantly."
"The AC Forum Resource Center is a goldmine of information. The resources are incredibly helpful and directly applicable to my daily practice. I frequently turn to the AC Forum website for guidance and support."
"The AC Forum webinars offer invaluable insights into treatment options and the decision-making process behind them. Each patient is unique, and weighing the benefits and risks can be challenging. "